Touch Screen Benefits:
• Real-time tumescence monitoring allows surgeons to make optimal nerve sparing decisions.

• Graphical display gives surgeons continuous feedback of penile tumescence allowing for quick response interpretation.

• Bold graphics, clearly visible from the operating table, combined with audible tones.

• Advanced stimulation algorithm allows for nerve identification optimization.

• Tumescence response analysis: Print record for archive and evaluation.

CD-Rom and
Floppy Disk

Optional Thermal Printer

Prostate surgery requires a customized nerve sparing approach because each patient’s anatomy, disease stage, and cancer location are unique. The most experienced surgeons have difficulty in visual approximation of the hidden and sensitive cavernosal nerves.  Doctors and their patients are frustrated in having to wait 6 months to a year to determine if the nerve sparing procedure was successful. In addition, popular drugs used in ED treatment are not effective on patients whose nerves are damaged during surgery.¹

CaverMap Surgical Aid allows a surgeon to identify and map the sensitive cavernosal nerves responsible for potency. The system precisely applies a mild electrical stimulation for a measured tumescence response. The CaverMap diagnostic allows a surgeon to detect and avoid the nerves course around the prostate, thereby improving their nerve sparing standards.  A positive response verifies nerve intactness after the cancer is removed. CaverMap helps optimize nerve sparing technique by enhancing surgical decisions with measured feedback.

Using state-of-the-art electronics, the CaverMap Surgical Aid System delivers a break-through patented cavernosal nerve location technology. This next generation system integrates leading-edge nerve stimulation and ultra-sensitive sensing technologies with a new enhanced surgeon interface.

*data on file

What other surgeons are saying:

“The CaverMap® Surgical Aid has a high specificity in identifying the neurovascular bundle (NVB) during radical Prostatectomy²

“With a neurostimulator (CaverMap), the proximal end of the intact nerve is identified and is then marked with a suture. After resecting the nerve…a brisk response at the distal transected end positively confirms the location of the recipient nerve.”

Intra-Operative cavernous nerve stimulation with penile tumescence monitoring during nerve sparing radical prostatectomy: Results of a phase 3 trial.⁵

Quantitative assessment of the response to CaverMap nerve stimulation at Radical Prostatectomy.³

“While Post Radical Prostatectomy stimulation results correlated strongly with degree of Neurovascular preservation, the degree of penile tumescence/ detumescence was independently predictive of recovery of erectile function.”

"For each 1% increase in post RP maximum tumescence/detum. with CaverMap stimulation, the relative risk for recovery of erections was 1.22 (95CI) with 0.98-1.53." ³

Recommended Reading:
1. Treatment of erectile dysfunction after radical prostatectomy with Sildenafi l Citrate (Viagra). Craig D. Zippe et al. Dept. of Urology & Biostatistics and Andrology - Oncology research laboratory, The Cleveland Clinic Foundation; and Lutheran Hospital, Cleveland Ohio, July 1998
2. The Cavermap Surgical Aid ® has high specifi city in identifying the neurovascular bundle (NVB) during radical prostatectomy. Pierre I Karakeiewicz, Sharokh Shariat, John Gore, Amir Naderi, Peter Scardino, and Kevin Slawin, New York, New York, and Houston TX. Accepted for publication at the 2001 annual meeting of the American Urological Association.
3. Quantitative assessment of the response to Cavermap® nerve stimulation at radical prostatectomy. Farhang Rabbani, NY, NY; Paul Cozzi, Sydney Australia; Peter T. Scardino, NY, NY. 
4. The rationale for and results of nerve grafting during radical prostatectomy. Peter Scardino, Edward Kim, UROLOGY 57, 2001
5. Intra-Operative cavernous nerve stimulation with penile tumescence monitoring during nerve sparing radical prostatectomy: results of a phase 3 trial. Laurence Klotz, Michael Jewett, and Sender Herschorn, Toronto; S. Larry Goldenberg, Martin Gleve, Vancouver; Jeremy Heaton, Kingston; Richard Casey, Oakville; and Joseph Chin, London, Canada.